PPARG and neoplasm: Several publications demonstrated that PPARγ activation suppresses COX-2 expression (Mendez and LaPointe, 2003) and a dual sEH/PPARγ could potentially circumvents the tumor promoting effects of (COX)-derived metabolites of EETs.